Chris I. Flowers - Concepedia

Author

Chris I. Flowers

University of California, San Francisco ORCID

Also Known As

C Flowers, C I Flowers, Chris Flowers, Chris I Flowers, Chris I. Flowers, Miglioretti, Diana L.

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Moffitt Cancer Center Group Health Cooperative University of South Florida University of Chicago

About

Chris I. Flowers is an author at University of California, San Francisco specializing in medicine, radiology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	677
2	Engineering	2	2	89
3	Health Sciences	2	2	89
4	Education	1	1	12
5	Public Health	1	1	411

Chris I. Flowers

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography Rebecca A. Hubbard, Karla Kerlikowske, Chris I. Flowers, Annals of Internal Medicine Breast OncologyEpidemiology Of CancerDiagnosisBiopsy RecommendationIncident Breast Cancer	2011	411
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer Elisabeth R. Garwood, Anjali S. Kumar, Frederick L. Baehner, Breast Cancer Research and Treatment Breast OncologyOncologyChemoprevention StrategyMedicineCell Death	2009	216
Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based Analysis Nabil F. Saba, Michael Goodman, Kevin C. Ward, Oncology	2011	126
Compositional breast imaging using a dual‐energy mammography protocol Aurélie Laidevant, Serghei Malkov, Chris I. Flowers, Medical Physics	2009	72
Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography Amie Y. Lee, Dorota J. Wisner, Shadi Aminololama‐Shakeri, Academic Radiology EngineeringMedical ImagingDiagnostic MammographyBi-rads DescriptorsCancer Detection	2016	64
Benefit of Semiannual Ipsilateral Mammographic Surveillance Following Breast Conservation Therapy Vignesh A. Arasu, Bonnie N. Joe, Natalya M. Lvoff, Radiology	2012	59
Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens Varsha Shah, Chris I. Flowers, A G Douglas‐Jones, Histopathology	2006	47
Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention Chris I. Flowers, Cristina O’Donoghue, Dan H. Moore, Breast Cancer Research and Treatment	2013	45
A unifying theory of carcinogenesis, and why targeted therapy doesn’t work Robert J. Gillies, Chris I. Flowers, Jennifer S. Drukteinis, European Journal of Radiology Drug TargetingUnifying TheoryTumor TargetingTargeted TherapyCancer Treatment	2012	38
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Rebecca A. Hubbard, Karla Kerlikowske, Chris I. Flowers, PubMed	2011	31

Page 1